| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |